NO20032111D0 - New drug compositions based on tiotropium salts and on salmeterol salts - Google Patents

New drug compositions based on tiotropium salts and on salmeterol salts

Info

Publication number: NO20032111D0
Authority: NO; Norway
Prior art keywords: salts; new drug; compositions based; salmeterol; drug compositions
Prior art date: 2000-11-13

Application number

NO20032111A

Other languages

Norwegian (no)

Other versions

NO20032111L (en

Inventor

Juergen Nagel

Christel Schmelzer

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-13

Filing date

2003-05-12

Publication date

2003-05-12

2003-05-12 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-05-12 Publication of NO20032111D0 publication Critical patent/NO20032111D0/en

2003-07-08 Publication of NO20032111L publication Critical patent/NO20032111L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Immunology (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20032111A 2000-11-13 2003-05-12 New drug mixtures based on tiotropium salts and on salmeterol salts NO20032111L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10056104A DE10056104A1 (en)	2000-11-13	2000-11-13	Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts
PCT/EP2001/012962 WO2002038154A1 (en)	2000-11-13	2001-11-09	Novel medicament compositions based on tiotropium salts and on salmeterol salts

Publications (2)

Publication Number	Publication Date
NO20032111D0 true NO20032111D0 (en)	2003-05-12
NO20032111L NO20032111L (en)	2003-07-08

Family

ID=7663071

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20032111A NO20032111L (en)	2000-11-13	2003-05-12	New drug mixtures based on tiotropium salts and on salmeterol salts

Country Status (32)

Country	Link
EP (3)	EP1335728B1 (en)
JP (2)	JP4282322B2 (en)
KR (2)	KR100886094B1 (en)
CN (1)	CN1678318A (en)
AT (2)	ATE291428T1 (en)
AU (3)	AU2791002A (en)
BG (1)	BG107781A (en)
BR (1)	BR0115226A (en)
CA (1)	CA2429012A1 (en)
CY (1)	CY1106774T1 (en)
CZ (1)	CZ20031444A3 (en)
DE (3)	DE10056104A1 (en)
DK (2)	DK1514546T3 (en)
EA (1)	EA007904B1 (en)
EC (1)	ECSP034571A (en)
EE (1)	EE200300228A (en)
ES (2)	ES2240549T3 (en)
HR (1)	HRP20030378A2 (en)
HU (1)	HUP0301447A3 (en)
IL (2)	IL155718A0 (en)
MX (1)	MXPA03004164A (en)
NO (1)	NO20032111L (en)
NZ (1)	NZ526400A (en)
PL (1)	PL205330B1 (en)
PT (2)	PT1514546E (en)
RS (2)	RS20090105A (en)
SG (1)	SG167657A1 (en)
SI (2)	SI1514546T1 (en)
SK (2)	SK286950B6 (en)
UA (1)	UA74853C2 (en)
WO (1)	WO2002038154A1 (en)
ZA (1)	ZA200302921B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US7214687B2 (en)	1999-07-14	2007-05-08	Almirall Ag	Quinuclidine derivatives and medicinal compositions containing the same
WO2001037805A1 (en) *	1999-11-23	2001-05-31	Glaxo Group Limited	Pharmaceutical formulations of salmeterol
MXPA04002401A (en) *	2001-09-14	2004-05-31	Boehringer Ingelheim Pharma	Novel medicaments for inhalation.
US7311894B2 (en)	2002-03-28	2007-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations containing an anticholinergic
DE10214263A1 (en) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA suspension formulations containing an anticholinergic
US7244415B2 (en)	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
US7250426B2 (en)	2002-11-29	2007-07-31	Boehringer Ingelheim Pharma Gmbh & Co Kg	Tiotropium-containing pharmaceutical combination for inhalation
DE10256080A1 (en) *	2002-11-29	2004-06-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Combination medicinal product for inhalation containing tiotropium
EP1575588A1 (en) *	2002-12-16	2005-09-21	Boehringer Ingelheim Pharma GmbH & Co.KG	Tiotropium containing hfc solution formulations
UA83813C2 (en) *	2002-12-20	2008-08-26	Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг	Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate
DE10345065A1 (en) *	2003-09-26	2005-04-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosol formulation for inhalation containing an anticholinergic
RS20060292A (en) *	2003-11-03	2008-08-07	Boehringer Ingelheim International Gmbh.,	Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
EP2319844A1 (en) *	2003-11-03	2011-05-11	Boehringer Ingelheim International GmbH	Tiotropium salts, method for creating same and medicinal formulations containing same
ES2257152B1 (en) *	2004-05-31	2007-07-01	Laboratorios Almirall S.A.	COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS.
CA2569074C (en) *	2004-05-31	2012-12-18	Almirall Prodesfarma S.A.	Combinations comprising antimuscarinic agents and pde4 inhibitors
NZ563596A (en)	2005-05-02	2011-01-28	Boehringer Ingelheim Int	Crystalline form of tiotropium bromide anhydrate
JP2009504603A (en) *	2005-08-06	2009-02-05	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Method of treating dyspnea by administering a combination of tiotropium salt and salmeterol salt
ES2298049B1 (en)	2006-07-21	2009-10-20	Laboratorios Almirall S.A.	PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO.
EP2100598A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20120220557A1 (en) *	2011-02-17	2012-08-30	Chiesi Farmaceutici S.P.A.	Liquid propellant-free formulation comprising an antimuscarinic drug
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
JP6335798B2 (en) *	2012-02-28	2018-05-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	New propellant-containing tiotropium formulation
WO2015065222A1 (en) *	2013-10-28	2015-05-07	Шолекс Девелопмент Гмбх	Pharmaceutical inhaled drug with micronized tiotropium bromide as active ingredient for the treatment of bronchial asthma and chronic obstructive pulmonary disease and method for producing same
TW201835041A (en)	2017-02-17	2018-10-01	印度商托仁特生技有限公司	Compounds with Beta-Adrenergic Agonist and Antimuscarinic Activity
WO2019142214A1 (en) *	2018-01-19	2019-07-25	Cipla Limited	Pharmaceutical composition comprising tiotropium for inhalation
CN116196298A (en) *	2018-07-26	2023-06-02	四川海思科制药有限公司	Aerosol pharmaceutical composition containing glycopyrronium salt and preparation method and application thereof
CN111936124A (en) *	2018-07-26	2020-11-13	四川海思科制药有限公司	Aerosol pharmaceutical composition containing glycopyrronium salt and indacaterol salt, and preparation method and application thereof
US11826382B2 (en)	2020-05-01	2023-11-28	Tygrus, LLC	Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
WO2022119661A1 (en) *	2020-12-04	2022-06-09	Tygrus, LLC	THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
US11642372B2 (en)	2020-05-01	2023-05-09	Tygrus, LLC	Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US12042514B2 (en)	2020-05-01	2024-07-23	Tygrus, LLC	Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
IL303404A (en) *	2020-12-04	2023-08-01	Tygrus Llc	A therapeutic agent with low pH and low toxicity active against at least one pathogen intended for the treatment of patients with respiratory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU748867B2 (en) *	1998-07-24	2002-06-13	Jagotec Ag	Medicinal aerosol formulations
DE19835346A1 (en) *	1998-08-05	2000-02-10	Boehringer Ingelheim Pharma	Two-part capsule for pharmaceutical preparations for powder inhalers
DE19847971A1 (en) *	1998-10-17	1999-09-02	Schiering	Filter fire occurrence prevention method
DE19847970A1 (en) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Stable concentrated liquid formulation of inhalable drug, e.g. formoterol or salbutamol, in solution or suspension medium, used after dilution for treatment of respiratory disorders by inhalation
DE19921693A1 (en) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
DE19961300A1 (en) *	1999-12-18	2001-06-21	Asta Medica Ag	Storage system for medicinal products in powder form and inhaler equipped with them

2000
- 2000-11-13 DE DE10056104A patent/DE10056104A1/en not_active Withdrawn
2001
- 2001-09-11 UA UA2003065486A patent/UA74853C2/en unknown
- 2001-11-09 IL IL15571801A patent/IL155718A0/en unknown
- 2001-11-09 CZ CZ20031444A patent/CZ20031444A3/en unknown
- 2001-11-09 EE EEP200300228A patent/EE200300228A/en unknown
- 2001-11-09 PL PL365989A patent/PL205330B1/en not_active IP Right Cessation
- 2001-11-09 DE DE50105729T patent/DE50105729D1/en not_active Expired - Lifetime
- 2001-11-09 HR HR20030378A patent/HRP20030378A2/en not_active Application Discontinuation
- 2001-11-09 ES ES01989446T patent/ES2240549T3/en not_active Expired - Lifetime
- 2001-11-09 EP EP01989446A patent/EP1335728B1/en not_active Expired - Lifetime
- 2001-11-09 AT AT01989446T patent/ATE291428T1/en active
- 2001-11-09 JP JP2002540737A patent/JP4282322B2/en not_active Expired - Lifetime
- 2001-11-09 AU AU2791002A patent/AU2791002A/en active Pending
- 2001-11-09 KR KR1020037006434A patent/KR100886094B1/en not_active Expired - Fee Related
- 2001-11-09 PT PT04028508T patent/PT1514546E/en unknown
- 2001-11-09 SI SI200130751T patent/SI1514546T1/en unknown
- 2001-11-09 CN CNA018187773A patent/CN1678318A/en active Pending
- 2001-11-09 KR KR1020087020177A patent/KR100940752B1/en not_active Expired - Fee Related
- 2001-11-09 SK SK50015-2009A patent/SK286950B6/en not_active IP Right Cessation
- 2001-11-09 BR BR0115226-2A patent/BR0115226A/en not_active Application Discontinuation
- 2001-11-09 HU HU0301447A patent/HUP0301447A3/en unknown
- 2001-11-09 DK DK04028508T patent/DK1514546T3/en active
- 2001-11-09 DK DK01989446T patent/DK1335728T3/en active
- 2001-11-09 EP EP07104722A patent/EP1808174A1/en not_active Withdrawn
- 2001-11-09 MX MXPA03004164A patent/MXPA03004164A/en active IP Right Grant
- 2001-11-09 AT AT04028508T patent/ATE362761T1/en active
- 2001-11-09 SG SG200505149-5A patent/SG167657A1/en unknown
- 2001-11-09 SI SI200130347T patent/SI1335728T1/en unknown
- 2001-11-09 AU AU2002227910A patent/AU2002227910B2/en not_active Ceased
- 2001-11-09 RS RSP-2009/0105A patent/RS20090105A/en unknown
- 2001-11-09 PT PT01989446T patent/PT1335728E/en unknown
- 2001-11-09 CA CA002429012A patent/CA2429012A1/en not_active Abandoned
- 2001-11-09 WO PCT/EP2001/012962 patent/WO2002038154A1/en not_active Ceased
- 2001-11-09 RS YUP-355/03A patent/RS50286B/en unknown
- 2001-11-09 SK SK741-2003A patent/SK286939B6/en not_active IP Right Cessation
- 2001-11-09 EP EP04028508A patent/EP1514546B1/en not_active Expired - Lifetime
- 2001-11-09 ES ES04028508T patent/ES2287629T3/en not_active Expired - Lifetime
- 2001-11-09 EA EA200300503A patent/EA007904B1/en not_active IP Right Cessation
- 2001-11-09 NZ NZ526400A patent/NZ526400A/en unknown
- 2001-11-09 DE DE50112535T patent/DE50112535D1/en not_active Expired - Lifetime
2003
- 2003-04-14 ZA ZA200302921A patent/ZA200302921B/en unknown
- 2003-04-28 EC EC2003004571A patent/ECSP034571A/en unknown
- 2003-05-01 IL IL155718A patent/IL155718A/en not_active IP Right Cessation
- 2003-05-08 BG BG107781A patent/BG107781A/en unknown
- 2003-05-12 NO NO20032111A patent/NO20032111L/en not_active Application Discontinuation
2004
- 2004-12-08 JP JP2004355226A patent/JP4282594B2/en not_active Expired - Lifetime
2007
- 2007-05-22 AU AU2007202303A patent/AU2007202303B2/en not_active Ceased
- 2007-07-30 CY CY20071101011T patent/CY1106774T1/en unknown

Also Published As

Publication number	Publication date
DK1335728T3 (en)	2005-04-18
DE50112535D1 (en)	2007-07-05
YU35503A (en)	2006-05-25
EE200300228A (en)	2003-10-15
DE50105729D1 (en)	2005-04-28
RS20090105A (en)	2009-07-15
DE10056104A1 (en)	2002-05-23
ATE362761T1 (en)	2007-06-15
DK1514546T3 (en)	2007-09-24
ES2287629T3 (en)	2007-12-16
SG167657A1 (en)	2011-01-28
EP1514546B1 (en)	2007-05-23
PL365989A1 (en)	2005-01-24
ECSP034571A (en)	2003-06-25
ZA200302921B (en)	2004-04-19
PT1514546E (en)	2007-06-15
CN1678318A (en)	2005-10-05
SI1514546T1 (en)	2007-10-31
IL155718A0 (en)	2003-11-23
SI1335728T1 (en)	2005-08-31
NO20032111L (en)	2003-07-08
CZ20031444A3 (en)	2003-08-13
BR0115226A (en)	2003-10-07
SK286950B6 (en)	2009-08-06
KR20080079701A (en)	2008-09-01
NZ526400A (en)	2005-09-30
EP1335728A1 (en)	2003-08-20
KR20030065509A (en)	2003-08-06
ATE291428T1 (en)	2005-04-15
CA2429012A1 (en)	2002-05-16
WO2002038154A1 (en)	2002-05-16
RS50286B (en)	2009-09-08
AU2007202303A1 (en)	2007-06-14
SK7412003A3 (en)	2003-10-07
EA007904B1 (en)	2007-02-27
CY1106774T1 (en)	2012-05-23
JP2005068163A (en)	2005-03-17
UA74853C2 (en)	2006-02-15
SK286939B6 (en)	2009-07-06
JP4282322B2 (en)	2009-06-17
AU2791002A (en)	2002-05-21
HUP0301447A2 (en)	2003-10-28
IL155718A (en)	2010-06-30
HUP0301447A3 (en)	2007-10-29
HRP20030378A2 (en)	2005-04-30
AU2007202303B2 (en)	2010-01-21
EA200300503A1 (en)	2004-12-30
MXPA03004164A (en)	2005-08-16
PL205330B1 (en)	2010-04-30
JP4282594B2 (en)	2009-06-24
PT1335728E (en)	2005-05-31
AU2002227910B2 (en)	2007-03-01
KR100940752B1 (en)	2010-02-11
ES2240549T3 (en)	2005-10-16
EP1808174A1 (en)	2007-07-18
JP2004513146A (en)	2004-04-30
EP1335728B1 (en)	2005-03-23
BG107781A (en)	2004-06-30
KR100886094B1 (en)	2009-02-27
EP1514546A1 (en)	2005-03-16

Publication	Publication Date	Title
NO20032111D0 (en)	2003-05-12	New drug compositions based on tiotropium salts and on salmeterol salts
DK1178832T3 (en)	2003-11-03	New drug compositions based on tiotropium bromide and salmeterol
NO2023030I1 (en)	2023-08-17	Apixaban and pharmaceutical acceptable salts thereof
NO20033002D0 (en)	2003-06-30	New quinuclidine derivatives and medical compositions containing the same
NO20031744D0 (en)	2003-04-15	New non-imadazole compounds and pharmaceutical compositions comprising such
EE04331B1 (en)	2004-08-16	Fast dissolving oral dosage form
DK1263721T3 (en)	2011-01-03	Pharmaceutical compositions containing 3-aminoacetidine derivatives, novel derivatives and preparation thereof
DE60105922D1 (en)	2004-11-04	Portable, self-sufficient medication infusion device
ATE355271T1 (en)	2006-03-15	PHARMACEUTICAL COMPOSITION
NO20030627L (en)	2003-04-08	Hydrogel-driven drug dosage form
NO20025450L (en)	2002-11-14	New pharmaceutical composition
ATE359064T1 (en)	2007-05-15	PHARMACEUTICAL TRAMADOL SALTS
NO20015113L (en)	2001-12-19	New compounds, their preparation and use
NO20052855D0 (en)	2005-06-13	Phosphonoxycinazoline derivatives and their pharmaceutical use.
DK1301485T3 (en)	2007-11-05	New heteroaryl derivatives and their use as a drug
NO20020180L (en)	2002-03-13	New quinuclidine derivatives and medical compositions containing the same
ITTO20001224A0 (en)	2000-12-29	PORTABLE DEVICE FOR DRUG INFUSION.
NO20025029L (en)	2002-10-18	New epothilone derivatives, processes for their preparation and their pharmaceutical use
DK1429769T3 (en)	2009-05-11	New formulations and their use
DE60129238D1 (en)	2007-08-16	PHARMACEUTICAL COMPOSITION
NO20030156D0 (en)	2003-01-13	Pharmaceutical compositions and methods for their use
NO20030822L (en)	2003-03-31	New compounds and methods
DK1429770T3 (en)	2009-08-03	New formulations and their use
DE10291905D2 (en)	2004-05-27	Pharmaceutical composition
NO20031537L (en)	2003-06-04	New pharmaceutical compositions containing epinastine and pseudoephedrine

Legal Events

Date	Code	Title	Description
2011-04-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application